![](/img/cover-not-exists.png)
Impact of reduced dosing of lopinavir/ritonavir in virologically controlled HIV-infected patients: the Kaledose trial
Meynard, J.-L., Morand-Joubert, L., Lacombe, K., Poirier, J.-M., Slama, L., Valantin, M.-A., Girard, P.-M.Volume:
65
Language:
english
Journal:
Journal of Antimicrobial Chemotherapy
DOI:
10.1093/jac/dkp396
Date:
January, 2010
File:
PDF, 114 KB
english, 2010